Antifungals – Synergy, indifference and antagonism

Blog · Antifungal

Antifungals – Synergy, indifference and antagonism

A combination of antifungals is often used in cases of difficult-to-treat infections. What is the evidence in the literature about synergy, antagonism and indifference?

Drug 1Drug 2CandidaAspergillusCryptococcus neoformans
Amphotericin BEchinocandinIndifference
(survival – NA)
Synergy, Indifference
(Survival ↑)
Synergy
(survival – NA)
Amphotericin BFlucytosineSynergy, indifference
(Survival ↑)
Synergy, indifference, antagonism
(Survival ↑)
Synergy, indifference, antagonism
(Survival ↑/↓)
Amphotericin BAzolesAntagonism
(Survival ↔/↓/↑)
Synergy, indifference, antagonism
(Survival ↔/↓)
Indifference
(Survival ↑/↓)
EchinocandinAzolesSynergy (Ahmadi 2020)Synergy, indifference
(Survival ↑)
Indifference
(survival – NA)
AzolesFlucytosineSynergy, indifference, antagonism
(Survival ↑)
Synergy, indifference
(Survival ↑/↓)

L.Ostrosky-Zeichner, Combination antifungal therapy: a critical review of the evidence, Clinical Microbiology and Infection Volume 14, Supplement 4, May 2008, Pages 65-70

Disclaimer: This is for academic use only. Managing an infection is complex and depends on taking multiple factors into account. Please speak to your doctor for clinical advice. This article must never be used for clinical purposes.
Scroll to Top